deltatrials

Haemophilia a Trials in Nashville, United States

Conditions / Haemophilia a / Nashville, United States

Haemophilia a is a medical condition with active clinical research programs worldwide.

14 total trials for this combination

Showing top 10 of 14 trials

Trials

NCT ID Title Status Phase
NCT05053139 A Research Study Investigating Mim8 in Adults and Adolescents With Haemophilia A With or Without Inhibitors COMPLETED PHASE3
NCT00984126 Safety and Efficacy of Turoctocog Alfa (N8) in Prevention and On-demand Treatment of Bleeding Episodes in Subjects With Haemophilia A: An Extension to Trials NN7008-3543, NN7008-3545, NN7008-3600, NN7008-3893 and NN7008-4015 COMPLETED PHASE3
NCT03741881 A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6) COMPLETED —
NCT03528551 A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia A COMPLETED PHASE3
NCT00840086 Safety and Efficacy of Turoctocog Alfa in Haemophilia A Subjects COMPLETED PHASE3
NCT01480180 Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A COMPLETED PHASE3
NCT05685238 A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A (FRONTIER 4) ACTIVE_NOT_RECRUITING PHASE3
NCT01489111 Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A. COMPLETED PHASE3
NCT02137850 Safety and Efficacy of Turoctocog Alfa Pegol (N8-GP) in Previously Untreated Patients With Haemophilia A COMPLETED PHASE3
NCT01731600 A Multinational, Open-Label, Non-Controlled Trial on Safety, Efficacy and Pharmacokinetics of NNC 0129-0000-1003 in Previously Treated Paediatric Patients With Severe Haemophilia A COMPLETED PHASE3

Related Pages